Large gap with delayed quotes
|
Last quote
03/17/2025 -
21:15:00
|
Bid
03/17/2025 -
20:59:59
|
Bid Volume |
Ask
03/17/2025 -
20:59:59
|
Ask Volume |
|---|---|---|---|---|
|
315.97
+7.75
(
+2.51% )
|
315.97
|
400 |
316.32
|
2,600 |
Analysis date: 14.03.2025
Global Evaluation
Neutral
Neutral
The stock is classified in the neutral zone since 03.05.2024.
Interest
Strong
Strong
Three stars since 04.03.2025.
Earnings Rev Trend
Negative
Negative
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 07.02.2025 at a price of 283.97.
Evaluation
Undervalued
Undervalued
Based on its growth potential and our own criteria, we believe the share price is currently moderately undervalued.
MT Tech Trend
Positive
Positive
The forty day technical trend is positive since 25.02.2025.
4wk Rel Perf
20.98%
20.98%
The four-week dividend-adjusted overperformance versus SP500 is 20.98%.
Sensibility
Middle
Middle
The stock has been on the moderate-sensitivity level since 03.05.2024.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by -1.05%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 2.85%.
Mkt Cap in $bn
17.11
17.11
With a market capitalization >$8bn, MOLINA HEALTHCARE is considered a large-cap stock.
G/PE Ratio
1
1
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 0.9 indicates that the stock's price presents a discount to growth of
LT P/E
11.66
11.66
The estimated PE is for the year 2026.
LT Growth
11.62%
11.62%
The annualized growth estimate is for the current year to 2026.
Avg. Nb analysts
14
14
Over the last seven weeks, an average of 14 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
4
4
For 1% of index variation, the stock varies on average by 0.04%.
Correlation
0.02
0.02
Stock movements are totally independent of index variations.
Value at Risk
67.88
67.88
The value at risk is estimated at USD 67.88. The risk is therefore 22.02%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
28.07.2004
28.07.2004